vs
ICU MEDICAL INC（ICUI）与Dave & Buster's Entertainment, Inc.（PLAY）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Dave & Buster's Entertainment, Inc.的1.2倍（$540.7M vs $448.2M），ICU MEDICAL INC净利率更高（-2.9% vs -9.4%，领先6.5%），Dave & Buster's Entertainment, Inc.同比增速更快（-1.1% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-20.6M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -13.5%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
戴夫与巴斯特娱乐是总部位于美国达拉斯的餐饮娱乐企业，旗下每家门店都配备全套服务餐厅、酒吧以及名为“百万美元 midway”的游戏游乐区。截至2024年2月，该公司共开设162家门店，其中美国本土158家，波多黎各和加拿大各设2家门店，主打餐饮与休闲娱乐融合的消费体验。
ICUI vs PLAY — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $448.2M |
| 净利润 | $-15.7M | $-42.1M |
| 毛利率 | 37.5% | 85.8% |
| 营业利润率 | 1.0% | -3.6% |
| 净利率 | -2.9% | -9.4% |
| 营收同比 | -14.1% | -1.1% |
| 净利润同比 | 34.0% | -28.7% |
| 每股收益（稀释后） | $-0.63 | $-1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $448.2M | ||
| Q3 25 | $537.0M | $557.4M | ||
| Q2 25 | $548.9M | $567.7M | ||
| Q1 25 | $604.7M | $534.5M | ||
| Q4 24 | $629.8M | $453.0M | ||
| Q3 24 | $589.1M | $557.1M | ||
| Q2 24 | $596.5M | $588.1M | ||
| Q1 24 | $566.7M | $599.0M |
| Q4 25 | $-15.7M | $-42.1M | ||
| Q3 25 | $-3.4M | $11.4M | ||
| Q2 25 | $35.3M | $21.7M | ||
| Q1 25 | $-15.5M | $9.3M | ||
| Q4 24 | $-23.8M | $-32.7M | ||
| Q3 24 | $-33.0M | $40.3M | ||
| Q2 24 | $-21.4M | $41.4M | ||
| Q1 24 | $-39.5M | $36.1M |
| Q4 25 | 37.5% | 85.8% | ||
| Q3 25 | 37.4% | 86.3% | ||
| Q2 25 | 37.9% | 85.5% | ||
| Q1 25 | 34.7% | 85.5% | ||
| Q4 24 | 36.1% | 85.0% | ||
| Q3 24 | 34.8% | 85.3% | ||
| Q2 24 | 34.8% | 85.2% | ||
| Q1 24 | 32.7% | 84.1% |
| Q4 25 | 1.0% | -3.6% | ||
| Q3 25 | 2.6% | 9.5% | ||
| Q2 25 | 1.9% | 11.1% | ||
| Q1 25 | 2.1% | 8.3% | ||
| Q4 24 | 6.0% | 1.4% | ||
| Q3 24 | 1.4% | 15.2% | ||
| Q2 24 | 1.3% | 14.5% | ||
| Q1 24 | -1.9% | 14.9% |
| Q4 25 | -2.9% | -9.4% | ||
| Q3 25 | -0.6% | 2.0% | ||
| Q2 25 | 6.4% | 3.8% | ||
| Q1 25 | -2.6% | 1.7% | ||
| Q4 24 | -3.8% | -7.2% | ||
| Q3 24 | -5.6% | 7.2% | ||
| Q2 24 | -3.6% | 7.0% | ||
| Q1 24 | -7.0% | 6.0% |
| Q4 25 | $-0.63 | $-1.22 | ||
| Q3 25 | $-0.14 | $0.32 | ||
| Q2 25 | $1.43 | $0.62 | ||
| Q1 25 | $-0.63 | $0.32 | ||
| Q4 24 | $-0.97 | $-0.84 | ||
| Q3 24 | $-1.35 | $0.99 | ||
| Q2 24 | $-0.88 | $0.99 | ||
| Q1 24 | $-1.63 | $0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $13.6M |
| 总债务越低越好 | — | $1.6B |
| 股东权益账面价值 | $2.1B | $130.8M |
| 总资产 | $4.1B | $4.1B |
| 负债/权益比越低杠杆越低 | — | 12.17× |
8季度趋势，按日历期对齐
| Q4 25 | — | $13.6M | ||
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $11.9M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | $308.6M | $8.6M | ||
| Q3 24 | $312.5M | $13.1M | ||
| Q2 24 | $302.6M | $32.1M | ||
| Q1 24 | $251.4M | $37.3M |
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $2.1B | $130.8M | ||
| Q3 25 | $2.1B | $166.2M | ||
| Q2 25 | $2.1B | $146.8M | ||
| Q1 25 | $2.0B | $145.8M | ||
| Q4 24 | $2.0B | $226.6M | ||
| Q3 24 | $2.0B | $284.4M | ||
| Q2 24 | $2.0B | $292.5M | ||
| Q1 24 | $2.1B | $251.2M |
| Q4 25 | $4.1B | $4.1B | ||
| Q3 25 | $4.1B | $4.1B | ||
| Q2 25 | $4.1B | $4.1B | ||
| Q1 25 | $4.2B | $4.0B | ||
| Q4 24 | $4.2B | $3.9B | ||
| Q3 24 | $4.3B | $3.8B | ||
| Q2 24 | $4.3B | $3.8B | ||
| Q1 24 | $4.3B | $3.8B |
| Q4 25 | — | 12.17× | ||
| Q3 25 | — | 9.57× | ||
| Q2 25 | — | 10.98× | ||
| Q1 25 | — | 10.45× | ||
| Q4 24 | — | 6.58× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | 4.58× | ||
| Q1 24 | — | 5.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $58.0M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $-20.6M |
| 自由现金流率自由现金流/营收 | 6.6% | -4.6% |
| 资本支出强度资本支出/营收 | 4.6% | 17.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $-195.6M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $58.0M | ||
| Q3 25 | $56.7M | $34.0M | ||
| Q2 25 | $11.2M | $95.8M | ||
| Q1 25 | $51.3M | $108.9M | ||
| Q4 24 | $40.2M | $-7.2M | ||
| Q3 24 | $36.1M | $101.8M | ||
| Q2 24 | $82.0M | $108.8M | ||
| Q1 24 | $45.8M | $97.2M |
| Q4 25 | $36.0M | $-20.6M | ||
| Q3 25 | $27.6M | $-55.2M | ||
| Q2 25 | $-8.5M | $-58.8M | ||
| Q1 25 | $36.7M | $-61.0M | ||
| Q4 24 | $16.1M | $-138.4M | ||
| Q3 24 | $16.2M | $-14.3M | ||
| Q2 24 | $62.5M | $-4.2M | ||
| Q1 24 | $29.9M | $-25.4M |
| Q4 25 | 6.6% | -4.6% | ||
| Q3 25 | 5.1% | -9.9% | ||
| Q2 25 | -1.5% | -10.4% | ||
| Q1 25 | 6.1% | -11.4% | ||
| Q4 24 | 2.6% | -30.6% | ||
| Q3 24 | 2.7% | -2.6% | ||
| Q2 24 | 10.5% | -0.7% | ||
| Q1 24 | 5.3% | -4.2% |
| Q4 25 | 4.6% | 17.5% | ||
| Q3 25 | 5.4% | 16.0% | ||
| Q2 25 | 3.6% | 27.2% | ||
| Q1 25 | 2.4% | 31.8% | ||
| Q4 24 | 3.8% | 29.0% | ||
| Q3 24 | 3.4% | 20.8% | ||
| Q2 24 | 3.3% | 19.2% | ||
| Q1 24 | 2.8% | 20.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.98× | ||
| Q2 25 | 0.32× | 4.41× | ||
| Q1 25 | — | 11.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.53× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
PLAY
| Game Play Credit Usage | $273.1M | 61% |
| Food And Nonalcoholic Beverages | $115.1M | 26% |
| Alcoholic Beverage | $53.7M | 12% |
| Other Entertainment | $6.3M | 1% |
| Gift Card Revenue | $3.5M | 1% |
